Found 336 hits.
| 211 | Casale, T. B., Bernstein, J. A., Maurer, M. Saini, S. S., Trzaskoma, B., Chen, H., Grattan, C., GimenÚz-Arnau, A., Kaplan, A. P., and Rosén, K.+: Similar efficacy with Omalizumab in chronic idiopathic/spontaneous urticaria despite different background therapy. J. Allergy Clin. Immunol. Pract. 2015: 3; 743-750. IF: 5.42 |
| 134 | KocatĂŒrk, E.+, Weller, K., Martus, P., Aktas, S., Kavala, M., Sarigul, S., Baiardini, I., Canonica, G. W., Brzoza, Z., Kalogeromitros, and Maurer, M.: Turkish version of the chronic urticaria quality of life questionnaire: cultural adaption, assessment of reliability and validity. Acta Derm. Venereol. 2012: 92; 419-425. IF: 3.48 |
o.134
| 338 | Lakin, E., Church, M. K., Maurer, M.+, and Schmetzer, O.: On the lipophilic nature of the autoreactive IgE in chronic spontaneous urticaria. Theranostics 2019: 9; 829-836. IF: TBD (IF 2018: 8.06) |
| 265 | Weller, K.+, Maurer, M. Fridman, M., Supina, D., Schranz, J., and Magerl, M.: Health-related quality of life in hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. Allergy Asthma Proc. 2017: 38; 143-151. IF: 2.21 |
| 262 | Weller, K.+, Magerl, M., Peveling-Oberhag, A., Martus, P., Staubach, P., and Maurer, M.: The angioedema quality of life questionnaire (AE-QoL) â assessment of sensitivity to change and minimal clinically important difference. Allergy 2016: 71; 1203-1209. IF: 7.36 |
| 319 | Siebenhaar, F.+, Sander, B., Ho, L. H. T., Ellrich, A., Maurer, M. and Weller, K.: Development and validation of the mastocytosis activity score. Allergy 2018: 73; 1489-1496. IF: 6.77 |
| 155 | MĆynek, A., Vieira dos Santos, R., Ardelean, E., Weller, K., Magerl, M., Church, M. K., and Maurer, M.+: A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. Clin. Exp. Dermatol. 2013: 38; 360-366. IF: 1.23 |
o.155
| 240 | Siebenhaar, F.+, von Tschirnhaus, E., Hartmann, K., Rabenhorst, A., Staubach, P., Peveling-Oberhag, A., Wagner, N., Martus, P., Carter, M. C., Metcalfe, D. D., Church, M. K., Maurer, M. and Weller, K.: Development and Validation of the Mastocytosis Quality of Life questionnaire: MC-QoL. Allergy 2016: 71; 869-877. IF: 7.36 |
| 57 | Magerl, M., Schmolke, J, Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.+: Acquired cold urticaria symptoms can be safely prevented by Ebastine. Allergy 2007: 62; 1465-1468. IF: 5.01 |
| 161. | Klimek, L., Pfaar, O., Worm, M., Eiwegger, T., Hagemann, J., Ollert, M., Untersmayr, E., Hoffmann-Sommergruber, K., Vultaggio, A., Agache, I., Bavbek, S., Bossios, A., Casper, I., Chan, S., Chatzipetrou, A., Vogelberg, C., Firinu, D., Kauppi, P., Kolios, A., Kothari, A., Matucci, A., Palomares, O., SzĂ©pfalusi, Z., Pohl, W., Hötzenecker, W., Rosenkranz, A. R., Bergmann, K. C., Bieber, T., Buhl, R., Buters, J., Darsow, U., Keil, T., Kleine-Tebbe, J., Lau, S., Maurer, M., Merk, H., Mösges, R., Saloga, J., Staubach, P., Jappe, U., Rabe, K. F., Rabe, U., Vogelmeier, C., Biedermann, T., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Freudelsperger, L., MĂŒlleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Tomazic, P. V., Aberer, W., Fink-Wagner, A. H., Horak, F., Wöhrl, S., Niederberger-Leppin, V., Pali-Schöll, I., Pohl, W., Roller-Wirnsberger, R., Spranger, O., Valenta, R., Akdis, M., Matricardi, P. M., Spertini, F., Khaltaev, N., Michel, J. P., Nicod, L., Schmid-Grendelmeier, P., Idzko, M., Hamelmann, E., Jakob, T., Werfel, T., Wagenmann, M., Taube, C., Jensen-Jarolim, E., Korn, S., Hentges, F., Schwarze, J., O Mahony, L., Knol, E. F., Del Giacco, S., Chivato PĂ©rez, T., Bousquet, J., Bedbrook, A., Zuberbier, T., Akdis, C., Jutel, M.: Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ărzteverband Deutscher Allergologen (AeDA), Deutsche Gesellschaft fĂŒr Allergologie und Klinische Immunologie (DGAKI), Gesellschaft fĂŒr PĂ€diatrische Allergologie und Umweltmedizin (GPA), Ăsterreichische Gesellschaft fĂŒr Allergologie und Immunologie (ĂGAI), Luxemburgische Gesellschaft fĂŒr Allergologie und Immunologie (LGAI), Ăsterreichische Gesellschaft fĂŒr Pneumologie (ĂGP) in co-operation with the German, Austrian, and Swiss ARIA groups, and the European Academy of Allergy and Clinical Immunology (EAACI). Allergol. Select. 2020: 4; 53-68. IF: N/A |
r.161